218 related articles for article (PubMed ID: 33252422)
1. Cardiac and renal protective effects of 2,5-dimethylcelecoxib in angiotensin II and high-salt-induced hypertension model mice.
Yamamoto M; Takahashi-Yanaga F; Arioka M; Igawa K; Tomooka K; Yamaura K; Sasaguri T
J Hypertens; 2021 May; 39(5):892-903. PubMed ID: 33252422
[TBL] [Abstract][Full Text] [Related]
2. 2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation.
Fujita A; Takahashi-Yanaga F; Morimoto S; Yoshihara T; Arioka M; Igawa K; Tomooka K; Hoka S; Sasaguri T
Hypertens Res; 2017 Feb; 40(2):130-139. PubMed ID: 27628899
[TBL] [Abstract][Full Text] [Related]
3. 2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation.
Morishige S; Takahashi-Yanaga F; Ishikane S; Arioka M; Igawa K; Kuroo A; Tomooka K; Shiose A; Sasaguri T
Biochem Pharmacol; 2019 Oct; 168():82-90. PubMed ID: 31229551
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway.
Egashira I; Takahashi-Yanaga F; Nishida R; Arioka M; Igawa K; Tomooka K; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Kitazono T; Sasaguri T
Cancer Sci; 2017 Jan; 108(1):108-115. PubMed ID: 27761963
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib and 2,5-dimethyl-celecoxib prevent cardiac remodeling inhibiting Akt-mediated signal transduction in an inherited dilated cardiomyopathy mouse model.
Fan X; Takahashi-Yanaga F; Morimoto S; Zhan DY; Igawa K; Tomooka K; Sasaguri T
J Pharmacol Exp Ther; 2011 Jul; 338(1):2-11. PubMed ID: 21430081
[TBL] [Abstract][Full Text] [Related]
6. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
[TBL] [Abstract][Full Text] [Related]
7. Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats.
Richter CM; Godes M; Wagner C; Maser-Gluth C; Herzfeld S; Dorn M; Priem F; Slowinski T; Bauer C; Schneider W; Neumayer HH; Kurtz A; Hocher B
J Hypertens; 2004 Jan; 22(1):191-8. PubMed ID: 15106811
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction.
Jacobshagen C; Grüber M; Teucher N; Schmidt AG; Unsöld BW; Toischer K; Nguyen VP; Maier LS; Kögler H; Hasenfuss G
Eur J Heart Fail; 2008 Apr; 10(4):334-42. PubMed ID: 18343721
[TBL] [Abstract][Full Text] [Related]
9. 2,5-Dimethyl-celecoxib induces early termination of inflammatory responses by transient macrophage accumulation and inhibits the progression of cardiac remodeling in a mouse model of cryoinjury-induced myocardial infarction.
Kishigami T; Ishikane S; Arioka M; Igawa K; Nishimura Y; Takahashi-Yanaga F
J Pharmacol Sci; 2024 Feb; 154(2):97-107. PubMed ID: 38246733
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin regulates blood pressure and kidney injury in rats.
Xiao L; Xu B; Zhou L; Tan RJ; Zhou D; Fu H; Li A; Hou FF; Liu Y
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1313-1322. PubMed ID: 30710617
[TBL] [Abstract][Full Text] [Related]
11. Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension.
Hermann M; Shaw S; Kiss E; Camici G; Bühler N; Chenevard R; Lüscher TF; Gröne HJ; Ruschitzka F
Hypertension; 2005 Feb; 45(2):193-7. PubMed ID: 15630049
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
Peng H; Carretero OA; Alfie ME; Masura JA; Rhaleb NE
Hypertension; 2001 Mar; 37(3):974-80. PubMed ID: 11244026
[TBL] [Abstract][Full Text] [Related]
13. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib does not alter cardiovascular and renal function during dietary salt loading.
Wenner MM; Edwards DG; Ray CA; Rose WC; Gardner TJ; Stillabower M; Farquhar WB
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):543-9. PubMed ID: 21631568
[TBL] [Abstract][Full Text] [Related]
15. The chemokine receptor CX
Ahadzadeh E; Rosendahl A; Czesla D; Steffens P; Prüßner L; Meyer-Schwesinger C; Wanner N; Paust HJ; Huber TB; Stahl RAK; Wiech T; Kurts C; Seniuk A; Ehmke H; Wenzel UO
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1526-F1535. PubMed ID: 30207169
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cells.
Cuevas CA; Gonzalez AA; Inestrosa NC; Vio CP; Prieto MC
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F358-65. PubMed ID: 25411386
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated β-catenin pathway.
Zhang S; Da L; Yang X; Feng D; Yin R; Li M; Zhang Z; Jiang F; Xu L
Toxicol Lett; 2014 Mar; 225(2):201-7. PubMed ID: 24374173
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
19. Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion.
Fujishima Y; Maeda N; Matsuda K; Komura N; Hirata A; Mori T; Sekimoto R; Tsushima Y; Nishizawa H; Funahashi T; Shimomura I
Biochem Biophys Res Commun; 2014 Feb; 444(2):224-9. PubMed ID: 24462873
[TBL] [Abstract][Full Text] [Related]
20. Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
Maier TJ; Janssen A; Schmidt R; Geisslinger G; Grösch S
FASEB J; 2005 Aug; 19(10):1353-5. PubMed ID: 15946992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
